IL101244A - A crystalline form of cyclosporine and pharmaceutical preparations containing it for pulmonary administration - Google Patents

A crystalline form of cyclosporine and pharmaceutical preparations containing it for pulmonary administration

Info

Publication number
IL101244A
IL101244A IL10124492A IL10124492A IL101244A IL 101244 A IL101244 A IL 101244A IL 10124492 A IL10124492 A IL 10124492A IL 10124492 A IL10124492 A IL 10124492A IL 101244 A IL101244 A IL 101244A
Authority
IL
Israel
Prior art keywords
iii
ciclosporin
administration
pulmonary administration
particulate form
Prior art date
Application number
IL10124492A
Other languages
English (en)
Hebrew (he)
Other versions
IL101244A0 (en
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of IL101244A0 publication Critical patent/IL101244A0/xx
Publication of IL101244A publication Critical patent/IL101244A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C07K7/645—Cyclosporins; Related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Dispersion Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL10124492A 1991-03-18 1992-03-16 A crystalline form of cyclosporine and pharmaceutical preparations containing it for pulmonary administration IL101244A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919105705A GB9105705D0 (en) 1991-03-18 1991-03-18 Improvements in or relating to organic compounds

Publications (2)

Publication Number Publication Date
IL101244A0 IL101244A0 (en) 1992-11-15
IL101244A true IL101244A (en) 1996-10-31

Family

ID=10691762

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10124492A IL101244A (en) 1991-03-18 1992-03-16 A crystalline form of cyclosporine and pharmaceutical preparations containing it for pulmonary administration

Country Status (29)

Country Link
US (1) US5719123A (fr)
EP (1) EP0504760B1 (fr)
JP (1) JP2549794B2 (fr)
KR (1) KR920017644A (fr)
AT (1) AT404553B (fr)
AU (1) AU658172B2 (fr)
CA (1) CA2063106C (fr)
CH (1) CH685229A5 (fr)
CZ (1) CZ281260B6 (fr)
DE (1) DE4208258B4 (fr)
DK (1) DK0504760T3 (fr)
ES (1) ES2093130T3 (fr)
FI (1) FI921125A (fr)
FR (1) FR2674249A1 (fr)
GB (2) GB9105705D0 (fr)
GR (1) GR3021497T3 (fr)
HU (1) HU208492B (fr)
IE (1) IE67627B1 (fr)
IL (1) IL101244A (fr)
IT (1) IT1255040B (fr)
LU (1) LU88087A1 (fr)
MX (1) MX9201141A (fr)
NO (1) NO310754B1 (fr)
NZ (1) NZ241975A (fr)
RU (1) RU2098122C1 (fr)
SA (1) SA92120536B1 (fr)
SK (1) SK279576B6 (fr)
TW (1) TW215901B (fr)
ZA (1) ZA921987B (fr)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5837677B2 (ja) * 1981-01-13 1983-08-17 松下電器産業株式会社 誘導加熱調理器
JPH07111905B2 (ja) * 1987-07-23 1995-11-29 株式会社東芝 誘導加熱調理器の負荷適否検知回路
WO1993025198A1 (fr) * 1992-06-12 1993-12-23 Teijin Limited Poudre ultra-fine pour inhalation et production de cette poudre
US5512269A (en) * 1993-06-09 1996-04-30 Burroughs Wellcome, Co. Method of treating retained pulmonary secretions
PE44995A1 (es) * 1994-01-27 1995-12-18 Schering Corp Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias
JP2000514085A (ja) * 1996-07-08 2000-10-24 ローヌ―プーラン・ロウラー・リミテッド 医薬シクロスポリンａエーロゾル溶液処方物
ZA9711732B (en) 1996-12-31 1998-12-28 Quadrant Holdings Cambridge Methods and compositions for improvement bioavailability of bioactive agents for mucosal delivery
US5898028A (en) * 1997-03-20 1999-04-27 Novo Nordisk A/S Method for producing powder formulation comprising an insulin
TW581681B (en) * 1998-02-20 2004-04-01 Nektar Therapeutics Liquid crystal forms of cyclosporin
US20020006901A1 (en) * 1999-02-05 2002-01-17 Aldo T. Iacono Use of aerosolized cyclosporine for prevention and treatment of pulmonary disease
FI20002217A (fi) * 1999-12-30 2001-07-01 Orion Yhtymae Oyj Inhalaatiopartikkelit
FI20010115A0 (fi) * 2001-01-18 2001-01-18 Orion Corp Menetelmä nanopartikkelien valmistamiseksi
EP1435910B9 (fr) * 2001-10-19 2010-02-03 Isotechnika Inc. Nouveaux preconcentres en microemulsion d'analogues de cyclosporine
WO2004069223A2 (fr) * 2003-02-06 2004-08-19 Cipla Ltd Compositions pharmaceutiques et leurs utilisations
CA2516733C (fr) * 2003-02-21 2011-09-27 The University Of Bath Procede de production de particules
US20050059583A1 (en) * 2003-09-15 2005-03-17 Allergan, Inc. Methods of providing therapeutic effects using cyclosporin components
US20060078623A1 (en) * 2004-08-13 2006-04-13 Emisphere Technologies, Inc. Pharmaceutical formulations containing microparticles or nanoparticles of a delivery agent
US7135455B2 (en) * 2004-11-15 2006-11-14 Allergan, Inc Methods for the therapeutic use of cyclosporine components
US7151085B2 (en) 2004-11-15 2006-12-19 Allergan, Inc. Therapeutic methods using cyclosporine components
US20080052114A1 (en) * 2005-11-30 2008-02-28 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems and methods related to nutraceuticals
US8340944B2 (en) * 2005-11-30 2012-12-25 The Invention Science Fund I, Llc Computational and/or control systems and methods related to nutraceutical agent selection and dosing
US8000981B2 (en) 2005-11-30 2011-08-16 The Invention Science Fund I, Llc Methods and systems related to receiving nutraceutical associated information
US7974856B2 (en) 2005-11-30 2011-07-05 The Invention Science Fund I, Llc Computational systems and methods related to nutraceuticals
US20070174128A1 (en) * 2005-11-30 2007-07-26 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational and/or control systems related to individualized pharmaceutical and nutraceutical selection and packaging
US20080033763A1 (en) * 2005-11-30 2008-02-07 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems related to receiving nutraceutical associated information
US8068991B2 (en) * 2005-11-30 2011-11-29 The Invention Science Fund I, Llc Systems and methods for transmitting pathogen related information and responding
US10296720B2 (en) * 2005-11-30 2019-05-21 Gearbox Llc Computational systems and methods related to nutraceuticals
US7927787B2 (en) * 2006-06-28 2011-04-19 The Invention Science Fund I, Llc Methods and systems for analysis of nutraceutical associated components
US20070124176A1 (en) * 2005-11-30 2007-05-31 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational and/or control systems and methods related to nutraceutical agent selection and dosing
US7827042B2 (en) * 2005-11-30 2010-11-02 The Invention Science Fund I, Inc Methods and systems related to transmission of nutraceutical associated information
US20070124218A1 (en) * 2005-11-30 2007-05-31 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational and/or control systems related to individualized nutraceutical selection and packaging
US20080004905A1 (en) * 2006-06-28 2008-01-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for analysis of nutraceutical associated components
US20070289258A1 (en) * 2006-06-14 2007-12-20 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Individualized pharmaceutical selection and packaging
US20070136092A1 (en) * 2005-11-30 2007-06-14 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational and/or control systems related to individualized pharmaceutical and nutraceutical selection and packaging
US20110145009A1 (en) * 2005-11-30 2011-06-16 Jung Edward K Y Methods and systems related to transmission of nutraceutical associatd information
US8297028B2 (en) 2006-06-14 2012-10-30 The Invention Science Fund I, Llc Individualized pharmaceutical selection and packaging
US20080114577A1 (en) * 2005-11-30 2008-05-15 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational methods and systems associated with nutraceutical related assays
DE102006051512A1 (de) 2005-12-06 2007-06-14 Pari GmbH Spezialisten für effektive Inhalation Pharmazeutische Medikamentenzusammensetzungen mit Cyclosporin
US20070219127A1 (en) * 2006-03-20 2007-09-20 Walt John G Cyclosporin a compositions
EP2714720B1 (fr) * 2011-05-27 2018-12-26 Allergan, Inc. Forme cristalline de cyclosporine a, procédés de préparation et procédés d'utilisation associés
JO3410B1 (ar) 2011-06-07 2019-10-20 Otsuka Pharma Co Ltd تركيبة أريبيبرازول مجفف بالتبريد
KR102072252B1 (ko) * 2011-11-15 2020-01-31 알러간, 인코포레이티드 사이클로스포린 a 제2형 및 그의 제조방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU203564B (en) * 1987-12-21 1991-08-28 Sandoz Ag Process for producing new orthorombos cyclosporin without solvatation
CH679119A5 (fr) * 1988-05-13 1991-12-31 Sandoz Ag
GB8916901D0 (en) * 1989-07-24 1989-09-06 Sandoz Ltd Improvements in or relating to organic compounds

Also Published As

Publication number Publication date
AU658172B2 (en) 1995-04-06
DE4208258B4 (de) 2007-07-12
HU208492B (en) 1993-11-29
GB2253853B (en) 1995-04-26
JP2549794B2 (ja) 1996-10-30
CS78592A3 (en) 1992-10-14
NO921012L (no) 1992-09-21
ITRM920181A0 (it) 1992-03-17
TW215901B (fr) 1993-11-11
CA2063106A1 (fr) 1992-09-19
FI921125A (fi) 1992-09-19
GR3021497T3 (en) 1997-01-31
SA92120536B1 (ar) 2005-04-27
NO921012D0 (no) 1992-03-16
IL101244A0 (en) 1992-11-15
AT404553B (de) 1998-12-28
KR920017644A (ko) 1992-10-21
IE67627B1 (en) 1996-04-17
IE920839A1 (en) 1992-09-23
CA2063106C (fr) 2002-12-17
LU88087A1 (fr) 1993-10-27
EP0504760A1 (fr) 1992-09-23
FR2674249B1 (fr) 1995-05-12
ES2093130T3 (es) 1996-12-16
GB9105705D0 (en) 1991-05-01
FI921125A0 (fi) 1992-03-16
DK0504760T3 (da) 1996-12-23
SK279576B6 (sk) 1999-01-11
ZA921987B (en) 1993-09-20
MX9201141A (es) 1992-10-01
IT1255040B (it) 1995-10-13
RU2098122C1 (ru) 1997-12-10
FR2674249A1 (fr) 1992-09-25
NO310754B1 (no) 2001-08-27
US5719123A (en) 1998-02-17
DE4208258A1 (de) 1992-09-24
ITRM920181A1 (it) 1993-09-17
HUT61324A (en) 1992-12-28
HU9200735D0 (en) 1992-05-28
EP0504760B1 (fr) 1996-10-09
ATA53492A (de) 1998-05-15
CH685229A5 (de) 1995-05-15
CZ281260B6 (cs) 1996-07-17
AU1294092A (en) 1992-09-24
GB2253853A (en) 1992-09-23
NZ241975A (en) 1994-04-27
GB9205554D0 (en) 1992-04-29
JPH0585940A (ja) 1993-04-06

Similar Documents

Publication Publication Date Title
US5719123A (en) Ciclosporin form for pulmonary administration
US9566239B2 (en) Pharmaceutical formulations for dry powder inhalers
AU2011287711B2 (en) Dry powder formulation comprising a phosphodiesterase inhibitor
DE69631881T2 (de) Pulmonale verabreichung von medikamenten in aerosolform
JPH10509738A (ja) 乾燥粉末α１−アンチトリプシンの肺投与
JPH10510828A (ja) 賦形剤としてメレチトースを含む粉末製剤
JP2001506272A (ja) 肺用組成物において使用するための亜鉛非含有のインスリン結晶
EP0876814A1 (fr) Exipient pour inhalateur à poudre sèche, procédé de sa préparation et compositions pharmaceutiques la contenant
JP2003533472A (ja) 吸入用インスリン製剤
US20050026883A1 (en) Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
Sorgi et al. Imiquimod powder for inhalation to stimulate innate immunity
KR20070110418A (ko) 입자 및 그 입자를 함유하는 제제
CA3168421A1 (fr) Formulation liquide de gm-csf pour inhalation
CN114129546A (zh) 一种吸入用药物组合物

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
HC Change of name of proprietor(s)
KB Patent renewed
RH Patent void
KB Patent renewed
KB Patent renewed
EXP Patent expired